Advertisement

Index by author

July 01, 1993; Volume 44,Issue 1

A

  1. Abutidze, K

    1. Reconstitution of glutamate receptor proteins purified from Xenopus central nervous system into artificial bilayers.
      C J Kerry, H L Sudan, K Abutidze, I R Mellor, E A Barnard and P N Usherwood
      Molecular Pharmacology July 1993, 44 (1) 142-152;

  2. Alexander, R W

    1. A cloned angiotensin receptor isoform from the turkey adrenal gland is pharmacologically distinct from mammalian angiotensin receptors.
      T J Murphy, Y Nakamura, K Takeuchi and R W Alexander
      Molecular Pharmacology July 1993, 44 (1) 1-7;

B

  1. Baker, S A

    1. Functional role for the M2 muscarinic receptor in smooth muscle of guinea pig ileum.
      E A Thomas, S A Baker and F J Ehlert
      Molecular Pharmacology July 1993, 44 (1) 102-110;

  2. Banerjee, D

    1. Mutations leading to antifolate resistance in Chinese hamster ovary cells after exposure to the alkylating agent ethylmethanesulfonate.
      R Fanin, D Banerjee, M Volkenandt, M Waltham, W W Li, A P Dicker, B I Schweitzer and J R Bertino
      Molecular Pharmacology July 1993, 44 (1) 13-21;

  3. Barg, J

    1. Differential down- and up-regulation of rat brain opioid receptor types and subtypes by buprenorphine.
      M M Belcheva, J Barg, R J McHale, S Dawn, M T Ho, E Ignatova and C J Coscia
      Molecular Pharmacology July 1993, 44 (1) 173-179;

  4. Barnard, E A

    1. Reconstitution of glutamate receptor proteins purified from Xenopus central nervous system into artificial bilayers.
      C J Kerry, H L Sudan, K Abutidze, I R Mellor, E A Barnard and P N Usherwood
      Molecular Pharmacology July 1993, 44 (1) 142-152;

  5. Barry, P H

    1. The extracellular disulfide loop motif of the inhibitory glycine receptor does not form the agonist binding site.
      R J Vandenberg, S Rajendra, C R French, P H Barry and P R Schofield
      Molecular Pharmacology July 1993, 44 (1) 198-203;

  6. Begleiter, A

    1. Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under acidic conditions.
      A Begleiter and M K Leith
      Molecular Pharmacology July 1993, 44 (1) 210-215;

  7. Belcheva, M M

    1. Differential down- and up-regulation of rat brain opioid receptor types and subtypes by buprenorphine.
      M M Belcheva, J Barg, R J McHale, S Dawn, M T Ho, E Ignatova and C J Coscia
      Molecular Pharmacology July 1993, 44 (1) 173-179;

  8. Bertino, J R

    1. Mutations leading to antifolate resistance in Chinese hamster ovary cells after exposure to the alkylating agent ethylmethanesulfonate.
      R Fanin, D Banerjee, M Volkenandt, M Waltham, W W Li, A P Dicker, B I Schweitzer and J R Bertino
      Molecular Pharmacology July 1993, 44 (1) 13-21;

  9. Brown, A M

    1. Barium blockade of a clonal potassium channel and its regulation by a critical pore residue.
      M Taglialatela, J A Drewe and A M Brown
      Molecular Pharmacology July 1993, 44 (1) 180-190;

  10. Buckpitt, A R

    1. Postnatal changes in the expression and distribution of pulmonary cytochrome P450 monooxygenases during Clara cell differentiation in rabbits.
      C G Plopper, A J Weir, D Morin, A Chang, R M Philpot and A R Buckpitt
      Molecular Pharmacology July 1993, 44 (1) 51-61;

C

  1. Carfagna, M A

    1. Interaction of tricyclic drug analogs with synaptic plasma membranes: structure-mechanism relationships in inhibition of neuronal Na+/K(+)-ATPase activity.
      M A Carfagna and B B Muhoberac
      Molecular Pharmacology July 1993, 44 (1) 129-141;

  2. Carr, C

    1. Direct measurements of in situ interactions of rat brain opioid receptors with the guanine nucleotide-binding protein Go.
      Z Georgoussi, C Carr and G Milligan
      Molecular Pharmacology July 1993, 44 (1) 62-69;

  3. Chang, A

    1. Postnatal changes in the expression and distribution of pulmonary cytochrome P450 monooxygenases during Clara cell differentiation in rabbits.
      C G Plopper, A J Weir, D Morin, A Chang, R M Philpot and A R Buckpitt
      Molecular Pharmacology July 1993, 44 (1) 51-61;

  4. Chen, Y

    1. Molecular cloning and functional expression of a mu-opioid receptor from rat brain.
      Y Chen, A Mestek, J Liu, J A Hurley and L Yu
      Molecular Pharmacology July 1993, 44 (1) 8-12;

  5. Chuang, D M

    1. Endothelin- and ATP-induced inhibition of adenylyl cyclase activity in C6 glioma cells: role of Gi and calcium.
      W W Lin and D M Chuang
      Molecular Pharmacology July 1993, 44 (1) 158-165;

  6. Coscia, C J

    1. Differential down- and up-regulation of rat brain opioid receptor types and subtypes by buprenorphine.
      M M Belcheva, J Barg, R J McHale, S Dawn, M T Ho, E Ignatova and C J Coscia
      Molecular Pharmacology July 1993, 44 (1) 173-179;

D

  1. Dawn, S

    1. Differential down- and up-regulation of rat brain opioid receptor types and subtypes by buprenorphine.
      M M Belcheva, J Barg, R J McHale, S Dawn, M T Ho, E Ignatova and C J Coscia
      Molecular Pharmacology July 1993, 44 (1) 173-179;

  2. Dicker, A P

    1. Mutations leading to antifolate resistance in Chinese hamster ovary cells after exposure to the alkylating agent ethylmethanesulfonate.
      R Fanin, D Banerjee, M Volkenandt, M Waltham, W W Li, A P Dicker, B I Schweitzer and J R Bertino
      Molecular Pharmacology July 1993, 44 (1) 13-21;

  3. Dolnick, B J

    1. 5-Fluorouracil alters dihydrofolate reductase pre-mRNA splicing as determined by quantitative polymerase chain reaction.
      X P Wu and B J Dolnick
      Molecular Pharmacology July 1993, 44 (1) 22-29;

  4. Drewe, J A

    1. Barium blockade of a clonal potassium channel and its regulation by a critical pore residue.
      M Taglialatela, J A Drewe and A M Brown
      Molecular Pharmacology July 1993, 44 (1) 180-190;

  5. Dubyak, G R

    1. Expression of the pore-forming P2Z purinoreceptor in Xenopus oocytes injected with poly(A)+ RNA from murine macrophages.
      L C Nuttle, C el-Moatassim and G R Dubyak
      Molecular Pharmacology July 1993, 44 (1) 93-101;

E

  1. Eason, M G

    1. Human alpha 2-adrenergic receptor subtype distribution: widespread and subtype-selective expression of alpha 2C10, alpha 2C4, and alpha 2C2 mRNA in multiple tissues.
      M G Eason and S B Liggett
      Molecular Pharmacology July 1993, 44 (1) 70-75;

  2. Ehlert, F J

    1. Functional role for the M2 muscarinic receptor in smooth muscle of guinea pig ileum.
      E A Thomas, S A Baker and F J Ehlert
      Molecular Pharmacology July 1993, 44 (1) 102-110;

  3. el-Moatassim, C

    1. Expression of the pore-forming P2Z purinoreceptor in Xenopus oocytes injected with poly(A)+ RNA from murine macrophages.
      L C Nuttle, C el-Moatassim and G R Dubyak
      Molecular Pharmacology July 1993, 44 (1) 93-101;

  4. Esbenshade, T A

    1. Comparison of alpha 1-adrenergic receptor subtypes and signal transduction in SK-N-MC and NB41A3 neuronal cell lines.
      T A Esbenshade, C Han, T J Murphy and K P Minneman
      Molecular Pharmacology July 1993, 44 (1) 76-86;

  5. Evans, C J

    1. Agonist-induced state of the delta-opioid receptor that discriminates between opioid peptides and opiate alkaloids.
      M Von Zastrow, D E Keith and C J Evans
      Molecular Pharmacology July 1993, 44 (1) 166-172;

F

  1. Fanin, R

    1. Mutations leading to antifolate resistance in Chinese hamster ovary cells after exposure to the alkylating agent ethylmethanesulfonate.
      R Fanin, D Banerjee, M Volkenandt, M Waltham, W W Li, A P Dicker, B I Schweitzer and J R Bertino
      Molecular Pharmacology July 1993, 44 (1) 13-21;

  2. Farb, D H

    1. Gamma-aminobutyric acidA receptor regulation: chronic treatment with pregnanolone uncouples allosteric interactions between steroid and benzodiazepine recognition sites.
      L Friedman, T T Gibbs and D H Farb
      Molecular Pharmacology July 1993, 44 (1) 191-197;

  3. French, C R

    1. The extracellular disulfide loop motif of the inhibitory glycine receptor does not form the agonist binding site.
      R J Vandenberg, S Rajendra, C R French, P H Barry and P R Schofield
      Molecular Pharmacology July 1993, 44 (1) 198-203;

  4. Fridland, A

    1. 5-Amino-4-imidazolecarboxamide riboside potentiates the metabolism and anti-human immunodeficiency virus activity of 2',3'-dideoxyinosine.
      Y F Gong, R V Srinivas and A Fridland
      Molecular Pharmacology July 1993, 44 (1) 30-36;

  5. Friedman, L

    1. Gamma-aminobutyric acidA receptor regulation: chronic treatment with pregnanolone uncouples allosteric interactions between steroid and benzodiazepine recognition sites.
      L Friedman, T T Gibbs and D H Farb
      Molecular Pharmacology July 1993, 44 (1) 191-197;

  6. Fuss, M

    1. Measurement of guanine nucleotide-binding protein activation by A1 adenosine receptor agonists in bovine brain membranes: stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding.
      A Lorenzen, M Fuss, H Vogt and U Schwabe
      Molecular Pharmacology July 1993, 44 (1) 115-123;

G

  1. Georgoussi, Z

    1. Direct measurements of in situ interactions of rat brain opioid receptors with the guanine nucleotide-binding protein Go.
      Z Georgoussi, C Carr and G Milligan
      Molecular Pharmacology July 1993, 44 (1) 62-69;

  2. Gibbs, T T

    1. Gamma-aminobutyric acidA receptor regulation: chronic treatment with pregnanolone uncouples allosteric interactions between steroid and benzodiazepine recognition sites.
      L Friedman, T T Gibbs and D H Farb
      Molecular Pharmacology July 1993, 44 (1) 191-197;

  3. Gong, Y F

    1. 5-Amino-4-imidazolecarboxamide riboside potentiates the metabolism and anti-human immunodeficiency virus activity of 2',3'-dideoxyinosine.
      Y F Gong, R V Srinivas and A Fridland
      Molecular Pharmacology July 1993, 44 (1) 30-36;

H

  1. Han, C

    1. Comparison of alpha 1-adrenergic receptor subtypes and signal transduction in SK-N-MC and NB41A3 neuronal cell lines.
      T A Esbenshade, C Han, T J Murphy and K P Minneman
      Molecular Pharmacology July 1993, 44 (1) 76-86;

  2. Hanna, P M

    1. Electron spin resonance evidence for free radical generation in copper-treated vitamin E- and selenium-deficient rats: in vivo spin-trapping investigation.
      M B Kadiiska, P M Hanna, S J Jordan and R P Mason
      Molecular Pharmacology July 1993, 44 (1) 222-227;

  3. Ho, M T

    1. Differential down- and up-regulation of rat brain opioid receptor types and subtypes by buprenorphine.
      M M Belcheva, J Barg, R J McHale, S Dawn, M T Ho, E Ignatova and C J Coscia
      Molecular Pharmacology July 1993, 44 (1) 173-179;

  4. Hurley, J A

    1. Molecular cloning and functional expression of a mu-opioid receptor from rat brain.
      Y Chen, A Mestek, J Liu, J A Hurley and L Yu
      Molecular Pharmacology July 1993, 44 (1) 8-12;

I

  1. Ignatova, E

    1. Differential down- and up-regulation of rat brain opioid receptor types and subtypes by buprenorphine.
      M M Belcheva, J Barg, R J McHale, S Dawn, M T Ho, E Ignatova and C J Coscia
      Molecular Pharmacology July 1993, 44 (1) 173-179;

J

  1. Johns, R A

    1. Regulation of nitric oxide synthase by nitric oxide.
      A Rengasamy and R A Johns
      Molecular Pharmacology July 1993, 44 (1) 124-128;

  2. Jordan, S J

    1. Electron spin resonance evidence for free radical generation in copper-treated vitamin E- and selenium-deficient rats: in vivo spin-trapping investigation.
      M B Kadiiska, P M Hanna, S J Jordan and R P Mason
      Molecular Pharmacology July 1993, 44 (1) 222-227;

K

  1. Kadiiska, M B

    1. Electron spin resonance evidence for free radical generation in copper-treated vitamin E- and selenium-deficient rats: in vivo spin-trapping investigation.
      M B Kadiiska, P M Hanna, S J Jordan and R P Mason
      Molecular Pharmacology July 1993, 44 (1) 222-227;

  2. Keith, D E

    1. Agonist-induced state of the delta-opioid receptor that discriminates between opioid peptides and opiate alkaloids.
      M Von Zastrow, D E Keith and C J Evans
      Molecular Pharmacology July 1993, 44 (1) 166-172;

  3. Kerry, C J

    1. Reconstitution of glutamate receptor proteins purified from Xenopus central nervous system into artificial bilayers.
      C J Kerry, H L Sudan, K Abutidze, I R Mellor, E A Barnard and P N Usherwood
      Molecular Pharmacology July 1993, 44 (1) 142-152;

  4. Kitada, M

    1. Characterization of human liver microsomal cytochrome P450 involved in the reductive metabolism of zonisamide.
      H Nakasa, M Komiya, S Ohmori, T Rikihisa, M Kiuchi and M Kitada
      Molecular Pharmacology July 1993, 44 (1) 216-221;

  5. Kiuchi, M

    1. Characterization of human liver microsomal cytochrome P450 involved in the reductive metabolism of zonisamide.
      H Nakasa, M Komiya, S Ohmori, T Rikihisa, M Kiuchi and M Kitada
      Molecular Pharmacology July 1993, 44 (1) 216-221;

  6. Kobilka, B K

    1. Amino acid substitutions at position 312 in the seventh hydrophobic segment of the beta 2-adrenergic receptor modify ligand-binding specificity.
      S Suryanarayana and B K Kobilka
      Molecular Pharmacology July 1993, 44 (1) 111-114;

  7. Komiya, M

    1. Characterization of human liver microsomal cytochrome P450 involved in the reductive metabolism of zonisamide.
      H Nakasa, M Komiya, S Ohmori, T Rikihisa, M Kiuchi and M Kitada
      Molecular Pharmacology July 1993, 44 (1) 216-221;

  8. Koropatnick, J

    1. Altered cisplatin and cadmium resistance and cell survival in Chinese hamster ovary cells expressing mouse metallothionein.
      J Koropatnick and J Pearson
      Molecular Pharmacology July 1993, 44 (1) 44-50;

  9. Korpi, E R

    1. Regional gamma-aminobutyric acid sensitivity of t-butylbicyclophosphoro[35S]thionate binding depends on gamma-aminobutyric acidA receptor alpha subunit.
      E R Korpi and H Lüddens
      Molecular Pharmacology July 1993, 44 (1) 87-92;

  10. Kumar, C S

    1. Novel endothelin receptors in the follicular membranes of Xenopus laevis oocytes mediate calcium responses by signal transduction through gap junctions.
      C S Kumar, P Nuthulaganti, M Pullen and P Nambi
      Molecular Pharmacology July 1993, 44 (1) 153-157;

L

  1. Leith, M K

    1. Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under acidic conditions.
      A Begleiter and M K Leith
      Molecular Pharmacology July 1993, 44 (1) 210-215;

  2. Li, W W

    1. Mutations leading to antifolate resistance in Chinese hamster ovary cells after exposure to the alkylating agent ethylmethanesulfonate.
      R Fanin, D Banerjee, M Volkenandt, M Waltham, W W Li, A P Dicker, B I Schweitzer and J R Bertino
      Molecular Pharmacology July 1993, 44 (1) 13-21;

  3. Liggett, S B

    1. Human alpha 2-adrenergic receptor subtype distribution: widespread and subtype-selective expression of alpha 2C10, alpha 2C4, and alpha 2C2 mRNA in multiple tissues.
      M G Eason and S B Liggett
      Molecular Pharmacology July 1993, 44 (1) 70-75;

  4. Lin, W W

    1. Endothelin- and ATP-induced inhibition of adenylyl cyclase activity in C6 glioma cells: role of Gi and calcium.
      W W Lin and D M Chuang
      Molecular Pharmacology July 1993, 44 (1) 158-165;

  5. Liu, J

    1. Molecular cloning and functional expression of a mu-opioid receptor from rat brain.
      Y Chen, A Mestek, J Liu, J A Hurley and L Yu
      Molecular Pharmacology July 1993, 44 (1) 8-12;

  6. Lorenzen, A

    1. Measurement of guanine nucleotide-binding protein activation by A1 adenosine receptor agonists in bovine brain membranes: stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding.
      A Lorenzen, M Fuss, H Vogt and U Schwabe
      Molecular Pharmacology July 1993, 44 (1) 115-123;

  7. Lüddens, H

    1. Regional gamma-aminobutyric acid sensitivity of t-butylbicyclophosphoro[35S]thionate binding depends on gamma-aminobutyric acidA receptor alpha subunit.
      E R Korpi and H Lüddens
      Molecular Pharmacology July 1993, 44 (1) 87-92;

M

  1. Malapetsa, A

    1. Transport of (2-chloroethyl)-3-sarcosinamide-1-nitrosourea in the human glioma cell line SK-MG-1 is mediated by an epinephrine-sensitive carrier system.
      A J Noë, A Malapetsa and L C Panasci
      Molecular Pharmacology July 1993, 44 (1) 204-209;

  2. Mason, R P

    1. Electron spin resonance evidence for free radical generation in copper-treated vitamin E- and selenium-deficient rats: in vivo spin-trapping investigation.
      M B Kadiiska, P M Hanna, S J Jordan and R P Mason
      Molecular Pharmacology July 1993, 44 (1) 222-227;

  3. McHale, R J

    1. Differential down- and up-regulation of rat brain opioid receptor types and subtypes by buprenorphine.
      M M Belcheva, J Barg, R J McHale, S Dawn, M T Ho, E Ignatova and C J Coscia
      Molecular Pharmacology July 1993, 44 (1) 173-179;

  4. Mellor, I R

    1. Reconstitution of glutamate receptor proteins purified from Xenopus central nervous system into artificial bilayers.
      C J Kerry, H L Sudan, K Abutidze, I R Mellor, E A Barnard and P N Usherwood
      Molecular Pharmacology July 1993, 44 (1) 142-152;

  5. Mestek, A

    1. Molecular cloning and functional expression of a mu-opioid receptor from rat brain.
      Y Chen, A Mestek, J Liu, J A Hurley and L Yu
      Molecular Pharmacology July 1993, 44 (1) 8-12;

  6. Miksicek, R J

    1. Commonly occurring plant flavonoids have estrogenic activity.
      R J Miksicek
      Molecular Pharmacology July 1993, 44 (1) 37-43;

  7. Milligan, G

    1. Direct measurements of in situ interactions of rat brain opioid receptors with the guanine nucleotide-binding protein Go.
      Z Georgoussi, C Carr and G Milligan
      Molecular Pharmacology July 1993, 44 (1) 62-69;

  8. Minneman, K P

    1. Comparison of alpha 1-adrenergic receptor subtypes and signal transduction in SK-N-MC and NB41A3 neuronal cell lines.
      T A Esbenshade, C Han, T J Murphy and K P Minneman
      Molecular Pharmacology July 1993, 44 (1) 76-86;

  9. Morin, D

    1. Postnatal changes in the expression and distribution of pulmonary cytochrome P450 monooxygenases during Clara cell differentiation in rabbits.
      C G Plopper, A J Weir, D Morin, A Chang, R M Philpot and A R Buckpitt
      Molecular Pharmacology July 1993, 44 (1) 51-61;

  10. Muhoberac, B B

    1. Interaction of tricyclic drug analogs with synaptic plasma membranes: structure-mechanism relationships in inhibition of neuronal Na+/K(+)-ATPase activity.
      M A Carfagna and B B Muhoberac
      Molecular Pharmacology July 1993, 44 (1) 129-141;

  11. Murphy, T J

    1. A cloned angiotensin receptor isoform from the turkey adrenal gland is pharmacologically distinct from mammalian angiotensin receptors.
      T J Murphy, Y Nakamura, K Takeuchi and R W Alexander
      Molecular Pharmacology July 1993, 44 (1) 1-7;
    2. Comparison of alpha 1-adrenergic receptor subtypes and signal transduction in SK-N-MC and NB41A3 neuronal cell lines.
      T A Esbenshade, C Han, T J Murphy and K P Minneman
      Molecular Pharmacology July 1993, 44 (1) 76-86;

N

  1. Nakamura, Y

    1. A cloned angiotensin receptor isoform from the turkey adrenal gland is pharmacologically distinct from mammalian angiotensin receptors.
      T J Murphy, Y Nakamura, K Takeuchi and R W Alexander
      Molecular Pharmacology July 1993, 44 (1) 1-7;

  2. Nakasa, H

    1. Characterization of human liver microsomal cytochrome P450 involved in the reductive metabolism of zonisamide.
      H Nakasa, M Komiya, S Ohmori, T Rikihisa, M Kiuchi and M Kitada
      Molecular Pharmacology July 1993, 44 (1) 216-221;

  3. Nambi, P

    1. Novel endothelin receptors in the follicular membranes of Xenopus laevis oocytes mediate calcium responses by signal transduction through gap junctions.
      C S Kumar, P Nuthulaganti, M Pullen and P Nambi
      Molecular Pharmacology July 1993, 44 (1) 153-157;

  4. Noë, A J

    1. Transport of (2-chloroethyl)-3-sarcosinamide-1-nitrosourea in the human glioma cell line SK-MG-1 is mediated by an epinephrine-sensitive carrier system.
      A J Noë, A Malapetsa and L C Panasci
      Molecular Pharmacology July 1993, 44 (1) 204-209;

  5. Nuthulaganti, P

    1. Novel endothelin receptors in the follicular membranes of Xenopus laevis oocytes mediate calcium responses by signal transduction through gap junctions.
      C S Kumar, P Nuthulaganti, M Pullen and P Nambi
      Molecular Pharmacology July 1993, 44 (1) 153-157;

  6. Nuttle, L C

    1. Expression of the pore-forming P2Z purinoreceptor in Xenopus oocytes injected with poly(A)+ RNA from murine macrophages.
      L C Nuttle, C el-Moatassim and G R Dubyak
      Molecular Pharmacology July 1993, 44 (1) 93-101;

O

  1. Ohmori, S

    1. Characterization of human liver microsomal cytochrome P450 involved in the reductive metabolism of zonisamide.
      H Nakasa, M Komiya, S Ohmori, T Rikihisa, M Kiuchi and M Kitada
      Molecular Pharmacology July 1993, 44 (1) 216-221;

P

  1. Panasci, L C

    1. Transport of (2-chloroethyl)-3-sarcosinamide-1-nitrosourea in the human glioma cell line SK-MG-1 is mediated by an epinephrine-sensitive carrier system.
      A J Noë, A Malapetsa and L C Panasci
      Molecular Pharmacology July 1993, 44 (1) 204-209;

  2. Pearson, J

    1. Altered cisplatin and cadmium resistance and cell survival in Chinese hamster ovary cells expressing mouse metallothionein.
      J Koropatnick and J Pearson
      Molecular Pharmacology July 1993, 44 (1) 44-50;

  3. Philpot, R M

    1. Postnatal changes in the expression and distribution of pulmonary cytochrome P450 monooxygenases during Clara cell differentiation in rabbits.
      C G Plopper, A J Weir, D Morin, A Chang, R M Philpot and A R Buckpitt
      Molecular Pharmacology July 1993, 44 (1) 51-61;

  4. Plopper, C G

    1. Postnatal changes in the expression and distribution of pulmonary cytochrome P450 monooxygenases during Clara cell differentiation in rabbits.
      C G Plopper, A J Weir, D Morin, A Chang, R M Philpot and A R Buckpitt
      Molecular Pharmacology July 1993, 44 (1) 51-61;

  5. Pullen, M

    1. Novel endothelin receptors in the follicular membranes of Xenopus laevis oocytes mediate calcium responses by signal transduction through gap junctions.
      C S Kumar, P Nuthulaganti, M Pullen and P Nambi
      Molecular Pharmacology July 1993, 44 (1) 153-157;

R

  1. Rajendra, S

    1. The extracellular disulfide loop motif of the inhibitory glycine receptor does not form the agonist binding site.
      R J Vandenberg, S Rajendra, C R French, P H Barry and P R Schofield
      Molecular Pharmacology July 1993, 44 (1) 198-203;

  2. Rengasamy, A

    1. Regulation of nitric oxide synthase by nitric oxide.
      A Rengasamy and R A Johns
      Molecular Pharmacology July 1993, 44 (1) 124-128;

  3. Rikihisa, T

    1. Characterization of human liver microsomal cytochrome P450 involved in the reductive metabolism of zonisamide.
      H Nakasa, M Komiya, S Ohmori, T Rikihisa, M Kiuchi and M Kitada
      Molecular Pharmacology July 1993, 44 (1) 216-221;

S

  1. Schofield, P R

    1. The extracellular disulfide loop motif of the inhibitory glycine receptor does not form the agonist binding site.
      R J Vandenberg, S Rajendra, C R French, P H Barry and P R Schofield
      Molecular Pharmacology July 1993, 44 (1) 198-203;

  2. Schwabe, U

    1. Measurement of guanine nucleotide-binding protein activation by A1 adenosine receptor agonists in bovine brain membranes: stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding.
      A Lorenzen, M Fuss, H Vogt and U Schwabe
      Molecular Pharmacology July 1993, 44 (1) 115-123;

  3. Schweitzer, B I

    1. Mutations leading to antifolate resistance in Chinese hamster ovary cells after exposure to the alkylating agent ethylmethanesulfonate.
      R Fanin, D Banerjee, M Volkenandt, M Waltham, W W Li, A P Dicker, B I Schweitzer and J R Bertino
      Molecular Pharmacology July 1993, 44 (1) 13-21;

  4. Srinivas, R V

    1. 5-Amino-4-imidazolecarboxamide riboside potentiates the metabolism and anti-human immunodeficiency virus activity of 2',3'-dideoxyinosine.
      Y F Gong, R V Srinivas and A Fridland
      Molecular Pharmacology July 1993, 44 (1) 30-36;

  5. Sudan, H L

    1. Reconstitution of glutamate receptor proteins purified from Xenopus central nervous system into artificial bilayers.
      C J Kerry, H L Sudan, K Abutidze, I R Mellor, E A Barnard and P N Usherwood
      Molecular Pharmacology July 1993, 44 (1) 142-152;

  6. Suryanarayana, S

    1. Amino acid substitutions at position 312 in the seventh hydrophobic segment of the beta 2-adrenergic receptor modify ligand-binding specificity.
      S Suryanarayana and B K Kobilka
      Molecular Pharmacology July 1993, 44 (1) 111-114;

T

  1. Taglialatela, M

    1. Barium blockade of a clonal potassium channel and its regulation by a critical pore residue.
      M Taglialatela, J A Drewe and A M Brown
      Molecular Pharmacology July 1993, 44 (1) 180-190;

  2. Takeuchi, K

    1. A cloned angiotensin receptor isoform from the turkey adrenal gland is pharmacologically distinct from mammalian angiotensin receptors.
      T J Murphy, Y Nakamura, K Takeuchi and R W Alexander
      Molecular Pharmacology July 1993, 44 (1) 1-7;

  3. Thomas, E A

    1. Functional role for the M2 muscarinic receptor in smooth muscle of guinea pig ileum.
      E A Thomas, S A Baker and F J Ehlert
      Molecular Pharmacology July 1993, 44 (1) 102-110;

U

  1. Usherwood, P N

    1. Reconstitution of glutamate receptor proteins purified from Xenopus central nervous system into artificial bilayers.
      C J Kerry, H L Sudan, K Abutidze, I R Mellor, E A Barnard and P N Usherwood
      Molecular Pharmacology July 1993, 44 (1) 142-152;

V

  1. Vandenberg, R J

    1. The extracellular disulfide loop motif of the inhibitory glycine receptor does not form the agonist binding site.
      R J Vandenberg, S Rajendra, C R French, P H Barry and P R Schofield
      Molecular Pharmacology July 1993, 44 (1) 198-203;

  2. Vogt, H

    1. Measurement of guanine nucleotide-binding protein activation by A1 adenosine receptor agonists in bovine brain membranes: stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding.
      A Lorenzen, M Fuss, H Vogt and U Schwabe
      Molecular Pharmacology July 1993, 44 (1) 115-123;

  3. Volkenandt, M

    1. Mutations leading to antifolate resistance in Chinese hamster ovary cells after exposure to the alkylating agent ethylmethanesulfonate.
      R Fanin, D Banerjee, M Volkenandt, M Waltham, W W Li, A P Dicker, B I Schweitzer and J R Bertino
      Molecular Pharmacology July 1993, 44 (1) 13-21;

  4. Von Zastrow, M

    1. Agonist-induced state of the delta-opioid receptor that discriminates between opioid peptides and opiate alkaloids.
      M Von Zastrow, D E Keith and C J Evans
      Molecular Pharmacology July 1993, 44 (1) 166-172;

W

  1. Waltham, M

    1. Mutations leading to antifolate resistance in Chinese hamster ovary cells after exposure to the alkylating agent ethylmethanesulfonate.
      R Fanin, D Banerjee, M Volkenandt, M Waltham, W W Li, A P Dicker, B I Schweitzer and J R Bertino
      Molecular Pharmacology July 1993, 44 (1) 13-21;

  2. Weir, A J

    1. Postnatal changes in the expression and distribution of pulmonary cytochrome P450 monooxygenases during Clara cell differentiation in rabbits.
      C G Plopper, A J Weir, D Morin, A Chang, R M Philpot and A R Buckpitt
      Molecular Pharmacology July 1993, 44 (1) 51-61;

  3. Wu, X P

    1. 5-Fluorouracil alters dihydrofolate reductase pre-mRNA splicing as determined by quantitative polymerase chain reaction.
      X P Wu and B J Dolnick
      Molecular Pharmacology July 1993, 44 (1) 22-29;

Y

  1. Yu, L

    1. Molecular cloning and functional expression of a mu-opioid receptor from rat brain.
      Y Chen, A Mestek, J Liu, J A Hurley and L Yu
      Molecular Pharmacology July 1993, 44 (1) 8-12;
Back to top

In this issue

Advertisement